Dermatology Market Research Reports 2026 — GCC & MENA Intelligence

Biologic psoriasis share battles overlap immunology classifications but topical JAK inhibition (rifacitinib class rollouts selectively ) plus phototherapy queue shortages anchor moderate disease segments. Chronic urticaria anti‑IgE and anti‑IgE adjunct histamine ladders coexist with climate‑driven eczema flares aggravated by chlorine pool tourism.